Skip to content

Evaluation of the merits and demerits of two different stenting methods in acute myocardial infarction patients

Evaluation of the merits and demerits of Deflated Balloon-Facilitated Direct Stenting method compared to the Predilation with balloon angioplasty technique in primary PCI patients, a randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250428065512N1
Enrollment
256
Registered
2025-05-13
Start date
2025-05-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ST-elevation myocardial infarction(STEMI). ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group:Deflated Balloon-Facilitated Direct Stenting method. Intervention 2: Intervention group:Predilation with balloon angioplasty.

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age 18 years and older, diagnosed with STEMI in the emergency department, having full criteria for primary PCI, and having informed consent

Exclusion criteria

Exclusion criteria: Cardiogenic shock, complete AV block, severe renal failure (serum creatinine > 3 mg/dL), need for emergency coronary artery bypass graft surgery

Design outcomes

Primary

MeasureTime frame
No-reflow phenomenon is referred to as the absence of blood flow after coronary artery re-opening. Variable measurement method: Based on angiographic criteria TIMI flow grade and TIMI frame count. TIMI Flow grade is as follows: Grade 0: No forward blood flow after the occlusion site. Grade 1: Poor forward coronary flow after the occlusion site and incomplete filling of the distal coronary bed.Grade 2: Partial blood flow Grade 3: Complete filling of the distal vessels following ventricular contraction. Timepoint: Before and immediately after primary angioplasty. Method of measurement: TIMI frame count (TFC) is assessed with coronary angiography and frames are numbered and counted to calculate the value, the first frame is defined as the frame in which more than 70% of the coronary artery lumen is filled with contrast material and the last frame is the frame in which the contrast material has reached the coronary end marker.The corrected TIMI frame count (TFC) is calculated by dividing the TFC of the left anterior descending artery by 1.7 . Normal TIMI frame count for the left anterior descending artery (LAD): 36 ± 3 (20 ± 3 for corrected TFC) for the left circumflex artery: 22 ± 4 for the right coronary artery: 20 ± 3.;ST-segment resolution (STR) is considered to be STR if the ST segment has returned to the isoelectric line by more than 70% 90 minutes after injection. Variable measurement method: All patients will have a standard 12-lead ECG at the beginning of their hospital stay and 90 minutes after PPCI. Timepoint: Before the intervention and 90 minutes after the intervention. Method of measurement: The total ST-segment elevation will be recorded 20 ms after the J point in all leads. After the total ST-segment elevation in the leads representing the infarct site on the baseline and 90-minute ECGs is calculated, the STR will be obtained by dividing the second number by the first number and subtracting it from 100, which will be expressed as a percentage.;Left ventr

Secondary

MeasureTime frame
Major adverse cardiac events (MACE), which in this study is a combination of cardiac death, non-fatal myocardial infarction, any revascularization, and stroke, are defined according to The Academic Research Consortium. Timepoint: Within 90 days after the intervention. Method of measurement: All patients will be followed for MACE for 90 days, either through a clinic visit or via telephone interview.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Faezeh Vaziri

Rasht University of Medical Sciences

vaziri.faezeh@yahoo.com+98 13 3366 9064

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026